Azelis India expands its distribution agreement with dsm-firmenich, becoming exclusive distributor of dsm-firmenich food enzymes and cultures across India; partnership will boost Azelis' value chain while enhancing market penetration for dsm-firmenich

Sample article from our Consumer packaged goods (CPG)

October 9, 2023 (press release) –

Azelis is pleased to announce the extension of its partnership with dsm-firmenich, a leading global innovator in nutrition, health, and beauty. Effective immediately, Azelis India will be the sole distributor of dsm-firmenich’s food enzymes and cultures range throughout India, a portfolio that includes dairy cultures, dairy enzymes, dairy test kits and bakery enzymes. This agreement expands Azelis India and dsm-firmenich partnership beyond the Western region to also cover India's Northern, Southern, and Eastern regions.

dsm-firmenich has over 150 years of expertise in innovation and a strong commitment to developing accessible solutions that serve to nourish, protect, and improve life. Thanks to their innovative portfolio, dsm-firmenich supports customers in the food & nutrition industry with ingredients that improve the taste, texture, and nutritional profile of formulations across a wide range of applications. This expanded partnership with dsm-firmenich strengthens Azelis’ lateral value chain with additional advanced solutions and enables the group to further meet market demand for sustainable formulations that enhance taste, and nutrition, and help improve life.

Christian Petersen, Regional Sales Manager Asia Pacific at dsm-firmenich, comments:

“Having partnered with Azelis India in the food market for more than a decade and pharma since 2022, we are pleased to expand that relationship to all of India for our enzymes and cultures portfolio for Food & Nutrition. This strategic decision has been made to streamline and enhance our distribution model in India to further increase our customer intimacy and strengthen our market penetration. We value Azelis as a trusted preferred partner with an excellent reputation, in-depth technical expertise and outstanding lab capabilities which are well-aligned with our technical solution-centric approach.”


Aparna Khurana, Managing Director of Azelis India, adds:

“We are thrilled about the expansion of our collaboration, a great recognition of the trust and confidence our valued principal dsm-firmenich has in our partnership. Our team has extensive knowledge of dsm-firmenich’s ingredients, and we are pleased to have the opportunity to share our expertise with a wider audience and support customers in dairy, bakery, nutrition, and more applications. Being able to exclusively offer dsm-firmenich’s advanced enzymes and cultures portfolio and nutrition solutions across India greatly expands our lateral value chain and nicely complements our current food and nutrition portfolio.”

For more information, please contact us at

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Dan Rivard
Dan Rivard
- VP Market Development -

We offer built-to-order consumer packaged goods (cpg) coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.